102 related articles for article (PubMed ID: 27051678)
1. Divalproex sodium: A potential therapy for scleroderma digital ulcers.
Urban JR; King B
JAAD Case Rep; 2015 Jan; 1(1):44-5. PubMed ID: 27051678
[No Abstract] [Full Text] [Related]
2. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression.
Young DA; Billingham O; Sampieri CL; Edwards DR; Clark IM
FEBS J; 2005 Apr; 272(8):1912-26. PubMed ID: 15819885
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts.
Rombouts K; Niki T; Greenwel P; Vandermonde A; Wielant A; Hellemans K; De Bleser P; Yoshida M; Schuppan D; Rojkind M; Geerts A
Exp Cell Res; 2002 Aug; 278(2):184-97. PubMed ID: 12169274
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
5. Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes.
Mogal A; Abdulkadir SA
Mol Cell Probes; 2006 Apr; 20(2):81-6. PubMed ID: 16326072
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A inhibits TGF-β1 induced in vitro chondrogenesis of hMSCs through Sp1 suppression.
Wang JP; Wen MH; Chen YT; Lee HH; Chiang ER; Lee YT; Liu CL; Chen TH; Hung SC
Differentiation; 2011 Feb; 81(2):119-26. PubMed ID: 21074928
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma.
Hou X; Wan H; Ai X; Shi Y; Ni Y; Tang W; Shi G
Clin Respir J; 2016 May; 10(3):371-9. PubMed ID: 25307458
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1.
Ghosh AK; Mori Y; Dowling E; Varga J
Biochem Biophys Res Commun; 2007 Mar; 354(2):420-6. PubMed ID: 17234156
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.
Hakami NY; Dusting GJ; Peshavariya HM
J Cell Mol Med; 2016 Oct; 20(10):1932-44. PubMed ID: 27297729
[TBL] [Abstract][Full Text] [Related]
11. Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells.
Bülow R; Fitzner B; Sparmann G; Emmrich J; Liebe S; Jaster R
Biochem Pharmacol; 2007 Dec; 74(12):1747-57. PubMed ID: 17889833
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
13. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
Park IH; Kang JH; Shin JM; Lee HM
PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
[TBL] [Abstract][Full Text] [Related]
15. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy.
Chen YT; Wei JD; Wang JP; Lee HH; Chiang ER; Lai HC; Chen LL; Lee YT; Tsai CC; Liu CL; Hung SC
Spine (Phila Pa 1976); 2011 Aug; 36(18):E1193-200. PubMed ID: 21343850
[TBL] [Abstract][Full Text] [Related]
16. Release of bio-active dentine extracellular matrix components by histone deacetylase inhibitors (HDACi).
Duncan HF; Smith AJ; Fleming GJ; Reid C; Smith G; Cooper PR
Int Endod J; 2017 Jan; 50(1):24-38. PubMed ID: 26609946
[TBL] [Abstract][Full Text] [Related]
17. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
[TBL] [Abstract][Full Text] [Related]
18. Radio- and chemo-sensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A.
Karagiannis TC; Smith AJ; El' Osta A
Hell J Nucl Med; 2004; 7(3):184-91. PubMed ID: 15841297
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin a inhibits phenotypic transition and induces apoptosis of the TAF-treated normal colonic epithelial cells through regulation of TGF-β pathway.
Huang C; Wu XF; Wang XL
Int J Biochem Cell Biol; 2019 Sep; 114():105565. PubMed ID: 31278993
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
Hemmatazad H; Rodrigues HM; Maurer B; Brentano F; Pileckyte M; Distler JH; Gay RE; Michel BA; Gay S; Huber LC; Distler O; Jüngel A
Arthritis Rheum; 2009 May; 60(5):1519-29. PubMed ID: 19404935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
